OnKure Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	36	115	-	-
Enterprise Value	-50	243	-	-
Last Close Price	2.40	8.60	-	-
PB Ratio	0.41	1.11	-	-
P/TBV Ratio	0.41	1.11	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.06
Quick Ratio	10.98	10.52	4.10	2.08
Current Ratio	11.13	10.73	4.64	2.46
Return on Equity (ROE)	-142.90%	-79.92%	-186.07%	-
Return on Assets (ROA)	-70.25%	-44.43%	-89.24%	-
Return on Capital (ROIC)	-85.48%	-50.10%	-117.58%	-
Earnings Yield	-186.01%	-45.91%	-	-
FCF Yield	-189.23%	-44.60%	-	-
Buyback Yield / Dilution	25.13%	-1114.54%	-	-

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q